NASDAQ:SSKN - STRATA Skin Sciences Stock Price, Forecast & News

STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."

STRATA Skin Sciences's stock reverse split before market open on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 9th 2014. An investor that had 100 shares of STRATA Skin Sciences stock prior to the reverse split would have 10 shares after the split.

STRATA Skin Sciences Inc (NASDAQ:SSKN) issued its earnings results on Monday, April, 20th. The medical device company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($0.37) by $0.77. STRATA Skin Sciences had a negative return on equity of 9.98% and a negative net margin of 9.74%. View STRATA Skin Sciences' Earnings History.

STRATA Skin Sciences is scheduled to release their next quarterly earnings announcement on Monday, March 2nd 2020. View Earnings Estimates for STRATA Skin Sciences.

4 brokerages have issued 1 year target prices for STRATA Skin Sciences' shares. Their forecasts range from $5.00 to $7.00. On average, they anticipate STRATA Skin Sciences' stock price to reach $6.06 in the next year. This suggests a possible upside of 281.3% from the stock's current price. View Analyst Price Targets for STRATA Skin Sciences.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STRATA Skin Sciences in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STRATA Skin Sciences.

News articles about SSKN stock have trended somewhat positive on Friday, InfoTrie reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. STRATA Skin Sciences earned a news sentiment score of 2.0 on InfoTrie's scale. They also assigned media coverage about the medical device company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for STRATA Skin Sciences.

STRATA Skin Sciences saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 21,500 shares, an increase of 225.8% from the January 15th total of 6,600 shares. Based on an average trading volume of 57,900 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.1% of the company's shares are sold short. View STRATA Skin Sciences' Current Options Chain.

Some companies that are related to STRATA Skin Sciences include Venus Concept (VERO), Vapotherm (VAPO), Soliton (SOLY), TELA Bio (TELA), Cytosorbents (CTSO), RenovaCare (RCAR), Pulse Biosciences (PLSE), Liquidia Technologies (LQDA), BRAINSWAY LTD/S (BWAY), Spectral Medical (EDTXF), PAVmed (PAVM), BeyondAirInc . (XAIR), Co-Diagnostics (CODX), SANUWAVE Health (SNWV) and AIT Therapeutics (AITB).

Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include Opko Health (OPK), NovaBay Pharmaceuticals (NBY), Agile Therapeutics (AGRX), Amarin (AMRN), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), Plug Power (PLUG), Strongbridge Biopharma (SBBP), Tonix Pharmaceuticals (TNXP) and Biocept (BIOC).

STRATA Skin Sciences' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Broadfin Capital LLC (5.59%), Renaissance Technologies LLC (3.52%), Cannell Capital LLC (1.40%), Goldman Sachs Group Inc. (0.60%), Acadian Asset Management LLC (0.17%) and Meitav Dash Investments Ltd. (0.08%). Company insiders that own STRATA Skin Sciences stock include James L Coyne, Luann Via, Matthew C Hill and Samuel E Navarro. View Institutional Ownership Trends for STRATA Skin Sciences.

SSKN stock was sold by a variety of institutional investors in the last quarter, including Broadfin Capital LLC, Meitav Dash Investments Ltd., Goldman Sachs Group Inc. and Acadian Asset Management LLC. View Insider Buying and Selling for STRATA Skin Sciences.

SSKN stock was bought by a variety of institutional investors in the last quarter, including Cannell Capital LLC and Renaissance Technologies LLC. Company insiders that have bought STRATA Skin Sciences stock in the last two years include James L Coyne, Luann Via, Matthew C Hill and Samuel E Navarro. View Insider Buying and Selling for STRATA Skin Sciences.

Shares of SSKN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SSKN stock can currently be purchased for approximately $1.59.

STRATA Skin Sciences has a market capitalization of $52.32 million and generates $29.85 million in revenue each year. STRATA Skin Sciences employs 98 workers across the globe.View Additional Information About STRATA Skin Sciences.

The official website for STRATA Skin Sciences is http://www.strataskinsciences.com/.

STRATA Skin Sciences' mailing address is 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044. The medical device company can be reached via phone at 215-619-3200 or via email at [email protected]